7,276 Shares in Teleflex Incorporated (NYSE:TFX) Acquired by Occudo Quantitative Strategies LP

Occudo Quantitative Strategies LP purchased a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 7,276 shares of the medical technology company's stock, valued at approximately $1,295,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Barclays PLC boosted its stake in shares of Teleflex by 1.6% in the third quarter. Barclays PLC now owns 89,907 shares of the medical technology company's stock valued at $22,233,000 after buying an additional 1,426 shares during the period. Franklin Resources Inc. boosted its stake in Teleflex by 64.3% in the third quarter. Franklin Resources Inc. now owns 9,683 shares of the medical technology company's stock valued at $2,298,000 after acquiring an additional 3,790 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of Teleflex by 2.7% during the 3rd quarter. Principal Financial Group Inc. now owns 80,409 shares of the medical technology company's stock valued at $19,887,000 after buying an additional 2,086 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Teleflex by 4.0% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,305 shares of the medical technology company's stock worth $588,000 after buying an additional 128 shares during the last quarter. Finally, Czech National Bank grew its holdings in Teleflex by 4.9% in the 4th quarter. Czech National Bank now owns 10,070 shares of the medical technology company's stock worth $1,792,000 after acquiring an additional 472 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Price Performance

Shares of TFX stock traded down $1.96 during mid-day trading on Monday, reaching $127.34. The company's stock had a trading volume of 92,473 shares, compared to its average volume of 636,550. The firm's 50-day moving average is $132.83 and its two-hundred day moving average is $162.37. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 1-year low of $120.06 and a 1-year high of $249.91. The company has a market cap of $5.63 billion, a P/E ratio of 25.30, a PEG ratio of 1.73 and a beta of 1.17.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex's revenue for the quarter was down 5.0% on a year-over-year basis. During the same period last year, the company posted $3.21 EPS. On average, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.07%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex's payout ratio is presently 42.90%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on TFX shares. Truist Financial decreased their price objective on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a report on Monday, May 5th. Piper Sandler reiterated a "neutral" rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Wells Fargo & Company reduced their price target on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Friday, May 2nd. Mizuho set a $155.00 target price on shares of Teleflex in a research report on Wednesday, April 16th. Finally, StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Teleflex presently has an average rating of "Hold" and an average price target of $164.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.